Could cause temporary or reversible harm; serious harm is unlikely.
Presence of foreign tablets/capsules.
| Brand name | METOCLOPRAMIDE |
| Generic name | METOCLOPRAMIDE |
| Active ingredient(s) | METOCLOPRAMIDE HYDROCHLORIDE |
| Distributed by / for | Teva Pharmaceuticals, Parsippany, NJ 07054 |
| NDC | 0093-2203-01 |
| Full product label | Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01. |
| Recalling firm | Teva Pharmaceuticals USA, Inc |
| Distribution | USA Nationwide |
| Quantity | 36612 cartons |
| Recall initiated | 2025-05-23 |
| Report date | 2025-07-02 |
| Recall completed | — |
| Recall number | D-0473-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗